Blood-based diagnostic tools
Flomics is developing these tools for a broad range of complex diseases.
Source: LinkedIn company description · Retrieved October 13, 2026
Flomics is developing blood-based diagnostic tools for a broad range of complex diseases.
Its technology identifies pattern changes in patients’ circulating long RNA molecules. Flomics uses deep learning algorithms to identify RNA changes associated with disease states.
Based on the company’s public LinkedIn information, supplied through RevenueBase.
Flomics is developing these tools for a broad range of complex diseases.
Source: LinkedIn company description · Retrieved October 13, 2026
Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.
Positions describe ordering within each source list. See how lists are built ↗
Embeddable award for your website
RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 4, 2026. Directory positions use company-contact counts from separate saved list snapshots dated September 5, 2026, September 19, 2026, October 8, 2026 and October 10, 2026. How the company lists are built.
Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.
Explore more companies by name, headquarters and business focus.